JPY4,297.00
0.54% yesterday
Tokyo, Jun 06, 08:08 am CET
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Takeda Pharmaceutical Stock price

JPY4,295.00
-124.00 2.81% 1M
+172.00 4.17% 6M
+114.00 2.73% YTD
+92.00 2.19% 1Y
+238.00 5.87% 5Y
-1,686.00 28.19% 10Y
-1,055.00 19.72% 20Y
Tokyo, Closing price Fri, Jun 06 2025
+21.00 0.49%
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Key metrics

Market capitalization JPY6.77t
Enterprise Value JPY10.88t
P/E (TTM) P/E ratio 62.86
EV/FCF (TTM) EV/FCF 15.34
EV/Sales (TTM) EV/Sales 2.38
P/S ratio (TTM) P/S ratio 1.48
P/B ratio (TTM) P/B ratio 0.97
Dividend yield 4.66%
Last dividend (FY26) JPY200.00
Revenue growth (TTM) Revenue growth 7.45%
Revenue (TTM) Revenue JPY4.58t
EBIT (operating result TTM) EBIT JPY342.59b
Free Cash Flow (TTM) Free Cash Flow JPY709.34b
Cash position JPY405.59b
EPS (TTM) EPS JPY68.33
P/E forward 25.59
P/S forward 1.48
EV/Sales forward 2.38
Show more

Is Takeda Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Takeda Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Takeda Pharmaceutical forecast:

8x Buy
50%
8x Hold
50%

Analyst Opinions

16 Analysts have issued a Takeda Pharmaceutical forecast:

Buy
50%
Hold
50%

Financial data from Takeda Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,581,551 4,581,551
7% 7%
100%
- Direct Costs 1,580,217 1,580,217
11% 11%
34%
3,001,334 3,001,334
6% 6%
66%
- Selling and Administrative Expenses 1,104,766 1,104,766
5% 5%
24%
- Research and Development Expense 730,227 730,227
0% 0%
16%
957,357 957,357
4% 4%
21%
- Depreciation and Amortization 614,771 614,771
18% 18%
13%
EBIT (Operating Income) EBIT 342,586 342,586
14% 14%
7%
Net Profit 107,928 107,928
25% 25%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Takeda Pharmaceutical Stock News

AD HOC NEWS
4 months ago
Takeda Pharmaceutical Company Limited / JP3463000004

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today